期刊文献+

替比夫定治疗慢性乙型肝炎50例疗效观察 被引量:1

下载PDF
导出
摘要 目的:研究替比夫定治疗慢性乙型肝炎的疗效。方法:将50例慢性乙型肝炎患者应用替比夫定抗病毒治疗,观察患者的症状、体征,在治疗第4周、8周、12周时检测患者肝功能及HBV DNA定量,观察治疗效果。结果:部分患者用药初期有肝功能波动,4周后氨酸氨基转氨酶(ALT)下降并逐渐恢复正常水平,HBV2DNA载量下降。结论:替比夫定可明显抑制乙型肝炎病毒复制,使已受感染的肝细胞产生病毒的能力受抑,并减少坏死后再生的肝细胞被病毒感染的机会,减轻肝脏炎症,利于肝功能恢复。需密切观察肝功能变化并及时调整综合治疗。
作者 张连春
出处 《临床医药实践》 2009年第2Z期1434-1435,共2页 Proceeding of Clinical Medicine
  • 相关文献

参考文献2

二级参考文献14

  • 1Bryant ML,Bridges EG,Placidi L,et al.Antiviral L-nucleosides specific for hepatitis B virus infection.Antimicrob Agents Chemother,2001,45:229-235.
  • 2Zhou XJ,Lloyd DM,Cbao GC,et al.Absence of food effect on the pharmacokinetics of telbivudine following oral administration in healthy subjects.J Clin Pharmacol,2006,46:275-281.
  • 3Zhou XJ,Lim SG,Lloyd DM,et al.Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection:pharmacodynamic implications.Antimicrob Agents Chemother,2006,50:874-879.
  • 4Lai,CL,Lim SG.A dose finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.Hepatology,2004,40:719-726.
  • 5Lai CL,Leung N,Teo EK,et al.A l-year trial of telbivudine,lamivudine,and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.Gastroenterology,2005,129:528-536.
  • 6Lai CL,Leung N,Teo EK,et al.Phase Ⅱb Extended-Treatment Trial of Telbivudine (LdT) vs.Lamivudine vs Combination Treatment in Hepatitis B Patients:Two-Year Results.DDW,Chicago,IL,USA.2005.
  • 7Lai CL,Gane E,Thongsawat S,et al.Telbivudine (LdT) vs.Lamivudine in the treatment of Chronic Hepatitis B:Results from GLOBE,an international Phase Ⅲ TriaL.Shanghai-Hong Kong International Liver Congress; 2006.
  • 8Lai CL,Gane E,Hsu CW,et al.Two-Year Results from the GLOBE Trial in Patients with Hepatitis B:Greater Clinical and Antiviral Efficacy for Telbivudine (LdT) vs Lamivudine.Hepatology,2006,44(4 Suppl 1):222A.
  • 9Hou JL,Yin YK,Xu DZ,et al.A phase Ⅲ comparative trial of telbivudine and lamivudine for treatment of chronic hepatitis B in Chinese patients:first year results.Presented at:Shanghai-Hong Kong International Liver Congress; 2006.
  • 10Bzowej N,Chan LYH,Lai CL,et al.A randomized trial of telbivudine(LdT) vs.adefovir for HBeAg-positive chronic hepatitis B:final week52 results.Hepatology,2006,44(4,Suppl 1):563A.

共引文献52

同被引文献15

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部